Yeo, Jian L.
Gulsin, Gaurav S.
Brady, Emer M.
Dattani, Abhishek
Bilak, Joanna M.
Marsh, Anna-Marie
Sian, Manjit
Athithan, Lavanya
Parke, Kelly S.
Wormleighton, Joanne
Graham-Brown, Matthew P. M.
Singh, Anvesha
Arnold, J. Ranjit
Lawson, Claire
Davies, Melanie J.
Xue, Hui
Kellman, Peter
McCann, Gerry P.
Clinical trials referenced in this document:
Documents that mention this clinical trial
156 Are current cut-offs to identify stage b heart failure (SBHF) appropriate in the UK?
https://doi.org/10.1136/heartjnl-2024-bcs.153
Association of ambulatory blood pressure with coronary microvascular and cardiac dysfunction in asymptomatic type 2 diabetes
https://doi.org/10.1186/s12933-022-01528-2
Epicardial adipose tissue in obesity-related cardiac dysfunction
https://doi.org/10.1136/heartjnl-2020-318242
Funding for this research was provided by:
National Institute for Health Research (RP-2017-08-ST2-007)
British Heart Foundation (FS/16/47/32190, FS/CRTF/20/24069, FS/18/26/33501)
Article History
Received: 24 April 2022
Accepted: 20 May 2022
First Online: 28 May 2022
Declarations
:
: Ethical approval was provided by the UK Health Research Authority Research Ethics Committee (reference 17/WM/0192). All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.